VRCA:NASDAQ, Verrica Pharmaceuticals Inc.

Why VRCA stock fell on November 5

Verrica Pharmaceuticals Inc. fell 10.6% on Thursday, November 5, 2026, on 121,376 shares. Headlines around the move:

VRCA stock overview

Verrica Pharmaceuticals Inc. (VRCA:NASDAQ) closed at $3.09 on November 5, 2026, down 10.56% on the day. The stock trades 68.5% below its 52-week high of $9.82 and 0.3% above its 52-week low of $3.08. Over the past year, it lost 13.7%. Verrica Pharmaceuticals Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$3.09
Day change
-10.56%
Volume
121,376
Average volume
70,837
Market cap
53M+
52-week range
$3.08 – $9.82
50-day average
$4.31
200-day average
$5.54

Price action over the past year

In 252 trading sessions since November 5, 2025, VRCA closed higher on 113 days (45%). Its best day was November 28, 2025 (+35.62%) and its worst was December 1, 2025 (-17.03%). The stock moved 10% or more in a single session 22 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

VRCA news

About Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs.

Similar stocks

Find more stocks like VRCA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.